662 related articles for article (PubMed ID: 9777411)
1. C1q and systemic lupus erythematosus.
Walport MJ; Davies KA; Botto M
Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
[TBL] [Abstract][Full Text] [Related]
2. C1q, autoimmunity and apoptosis.
Botto M; Walport MJ
Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
[TBL] [Abstract][Full Text] [Related]
3. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
Potlukova E; Kralikova P
Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
[TBL] [Abstract][Full Text] [Related]
4. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.
Botto M; Dell'Agnola C; Bygrave AE; Thompson EM; Cook HT; Petry F; Loos M; Pandolfi PP; Walport MJ
Nat Genet; 1998 May; 19(1):56-9. PubMed ID: 9590289
[TBL] [Abstract][Full Text] [Related]
5. C1q knock-out mice for the study of complement deficiency in autoimmune disease.
Botto M
Exp Clin Immunogenet; 1998; 15(4):231-4. PubMed ID: 10072632
[TBL] [Abstract][Full Text] [Related]
6. [Apoptosis and C1q: possible explanations for the pathogenesis of systemic lupus erythematosus].
Trendelenburg M; Schifferli JA
Z Rheumatol; 2000 Jun; 59(3):172-5. PubMed ID: 10929445
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
[TBL] [Abstract][Full Text] [Related]
8. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
Mevorach D
Apoptosis; 2010 Sep; 15(9):1114-23. PubMed ID: 20683667
[TBL] [Abstract][Full Text] [Related]
9. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
10. Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus?
Trendelenburg M; Courvoisier S; Späth PJ; Moll S; Mihatsch M; Itin P; Schifferli JA
Am J Kidney Dis; 1999 Oct; 34(4):745-51. PubMed ID: 10516358
[TBL] [Abstract][Full Text] [Related]
11. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
12. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
Holers VM
J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
[TBL] [Abstract][Full Text] [Related]
13. Relevance of anti-C1q autoantibodies to lupus nephritis.
Tsirogianni A; Pipi E; Soufleros K
Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
[TBL] [Abstract][Full Text] [Related]
14. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
[TBL] [Abstract][Full Text] [Related]
15. Anti C1q antibodies in cutaneous lupus erythematosus.
Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against C1q in patients with systemic lupus erythematosus.
Trendelenburg M
Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648
[TBL] [Abstract][Full Text] [Related]
17. Hereditary C1q deficiency and systemic lupus erythematosus.
Bowness P; Davies KA; Norsworthy PJ; Athanassiou P; Taylor-Wiedeman J; Borysiewicz LK; Meyer PA; Walport MJ
QJM; 1994 Aug; 87(8):455-64. PubMed ID: 7922299
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
20. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
